Favipiravir Bioanalysis [Regulatives / Guidelines]

posted by Ayman Rabayah – Jordan, 2020-08-11 08:44 (654 d 12:21 ago) – Posting: # 21854
Views: 1,345

Hellow colleagues
Need your feedback about the Bio-analysis of Favipiravir, do the metabolite (Favipiravir RTP) need to be measured or only the Favipiravir, since no FDA or EMEA related guidance issued till date.
Appreciate your thoughts.

Ayman Ahmad

Complete thread:

UA Flag
 Admin contact
22,110 posts in 4,630 threads, 1,567 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Friday 21:05 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz